Although Medicaid has been slower than Medicare to embrace value-based care, an increasing number of states are defining Medicaid value-based care delivery systems and payment reforms. While ...
Value-based care has been slowly gaining traction in the U.S. Some Rhode Island providers are trying to transition their practices away from fee-for-service and toward value-based care The key ...
In the U.S., we have two clear problems with healthcare: high costs and poor health outcomes. We spend around $5 trillion each year on healthcare—twice as much per person as other large, wealthy ...
There is still a clear need for high-quality, evidence-based behavioral health care in the United States and one way to get there is through innovative payment models, including value-based care ...
Just over three-quarters of health system and hospital C-suites say they plan to increase value-based care model participation within the next two years, up from the 57% who indicated similarly back ...
The way healthcare is paid for is one of the most powerful levers shaping the future of the industry. Reimbursement structures determine which treatments are offered, how clinicians spend their time ...
Value-based care continues to account for a substantial share of U.S. healthcare payments, underscoring sustained payer investment in payment models that link reimbursement to quality and cost ...
Arguably, one of the most important barriers to achieving value-based care is our inability to accurately extract and transmit clinically nuanced data, present in EHRs, to make inferences and ...
“Value-based care” (VBC) is one of the most frequently cited goals in U.S. healthcare reform — yet its meaning remains frustratingly vague and often contradictory. We hear that value-based care is the ...
Becker’s asked five health system strategic leaders about the role value-based care plays in their system’s strategic planning and how they’re managing the challenges it presents. If you are a COO or ...
Explore the latest advancements in oncology, including biomarkers and targeted therapies, enhancing patient care at Tennessee Oncology and Vanderbilt-Ingram Cancer Center. Cancer treatment has evolved ...
Transitioning to risk-based contracts showed no significant impact on low-value service use or overall healthcare utilization. Difference-in-differences analysis revealed some reductions in specific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results